• Bangalore
  • 5 February 2013
  • News
  • By Narayan

Dr Bernstein: India should increase its visibility

India has the best opportunity in biotechnology if it follows important factors like pre-competitiveness, where pooling of resources is necessary to understand diseases and this is made possible only by industry-academia collaboration

web-image

Dr Karen Bernstein, co-founder and chairman, BioCentury, USA, speaking at a session on Bangalore India Bio

"India fits in perfectly as a global biotech hub provided it can increase generic medicine for both internal and other emerging markets, high level of differentiation, chart a clear path to early exit, bring-in capital efficiency especially in venture level, develop professional, nimble and entrepreneurial management of companies," said Dr Karen Bernstein, co-founder and chairman, BioCentury, USA.

Speaking at a session on how India can leverage the biotech industry and the challenges for India in this sector at the Bangalore India Bio 2013 organized by the Department of Information Technology, Bio-Technology and Science and Technology, Government of Karnataka on February 4, 2013, Dr Karen Bernstein, said, "India has the best opportunity in biotechnology if it follows important factors like - pre-competitiveness where pooling of resources is necessary to understand diseases and this is only possible by industry-academic collaboration. There exists major gaps in basic sciences that are key to enabling innovations in novel therapeutics. Improving productivity through collaboration is needed. The key to success lies in focusing and addressing specific areas of science."

She further said, "In India, the problem is about misalignment of time line. The solution for this is differentiating single project companies from therapeutic platform companies and a novel corporate structure. In future, the biotech R&D will be globalized in multiple tracks, more presumptive collaborations will take place, system will be driven by patients, and the need to adopt to world austerity."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Taro Announces Appointment of Interim CEO

Friday, 2 Dec 2016   |   Taro Pharmaceutical Industries Ltd.

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”)

Florida's Parrish Medical Center is the First Hospital to Commit to All

Friday, 2 Dec 2016   |   Patient Safety Movement Foundation

Business Wire India The Patient Safety Movement Foundation (PSMF) is very proud to announce that Parrish

GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory

Friday, 2 Dec 2016   |   GVK BIO

Business Wire IndiaGVK Biosciences, one of Asia’s leading life sciences service organizations today

BusinessWire India.com - Pharmaceutical

Bwi-logo

Taro Announces Appointment of Interim CEO

Friday, 2 Dec 2016   |   Taro Pharmaceutical Industries Ltd.

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”)

The Bitter Truth About Sugar!

Wednesday, 30 Nov 2016   |   Manipal Hospitals

Business Wire IndiaOn average, an individual having three square meals a day consumes up to 148 grams

BusinessWire India.com - Medical Devices

Bwi-logo

BGS Global Hospital Performs Successful Use of Spy Glass to Treat Large

Thursday, 1 Dec 2016   |   BGS Global Hospitals

Business Wire India Spy Glass destroys stones that form in or become lodged in the Common Bile Duct

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X